These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10700428)

  • 21. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee.
    Bakker AC; Joosten LA; Arntz OJ; Helsen MM; Bendele AM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 1997 May; 40(5):893-900. PubMed ID: 9153551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies.
    Lewthwaite J; Blake S; Hardingham T; Foulkes R; Stephens S; Chaplin L; Emtage S; Catterall C; Short S; Nesbitt A
    Ann Rheum Dis; 1995 May; 54(5):366-74. PubMed ID: 7794042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune complexes, but not streptococcal cell walls or zymosan, cause chronic arthritis in mouse strains susceptible for collagen type II auto-immune arthritis.
    Blom AB; van Lent PL; Holthuysen AE; van den Berg WB
    Cytokine; 1999 Dec; 11(12):1046-56. PubMed ID: 10623430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
    van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
    Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of cartilage damage by overexpression of T cell interleukin-17A in experimental arthritis in mice deficient in interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Kolls JK; Joosten LA; van den Berg WB
    Arthritis Rheum; 2005 Mar; 52(3):975-83. PubMed ID: 15751058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats.
    Schwab JH; Anderle SK; Brown RR; Dalldorf FG; Thompson RC
    Infect Immun; 1991 Dec; 59(12):4436-42. PubMed ID: 1834576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenectomy attenuates streptococcal cell wall-induced arthritis and alters leukocyte activation.
    Kimpel D; Dayton T; Fuseler J; Gray L; Kannan K; Wolf RE; Grisham M
    Arthritis Rheum; 2003 Dec; 48(12):3557-67. PubMed ID: 14674009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis.
    Allen JB; Wong HL; Costa GL; Bienkowski MJ; Wahl SM
    J Immunol; 1993 Oct; 151(8):4344-51. PubMed ID: 8409406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment.
    Rioja I; Bush KA; Buckton JB; Dickson MC; Life PF
    Clin Exp Immunol; 2004 Jul; 137(1):65-73. PubMed ID: 15196245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritis.
    Marijnissen RJ; Koenders MI; van de Veerdonk FL; Dulos J; Netea MG; Boots AM; Joosten LA; van den Berg WB
    PLoS One; 2012; 7(6):e38889. PubMed ID: 22719976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell walls.
    Schrier DJ; Schimmer RC; Flory CM; Tung DK; Ward PA
    J Leukoc Biol; 1998 Mar; 63(3):359-63. PubMed ID: 9500524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model.
    Yang S; Wu B; Mayton L; Evans CH; Robbins PD; Wooley PH
    Inflamm Res; 2002 Jul; 51(7):342-50. PubMed ID: 12146725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
    Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
    J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-reactivity to proteoglycans in bacterial arthritis: lack of evidence for in vivo role in induction of disease.
    van de Langerijt AG; Kingston AE; van Lent PL; Billingham ME; van den Berg WB
    Clin Immunol Immunopathol; 1994 Jun; 71(3):273-80. PubMed ID: 7515334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
    Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
    Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.
    Sternberg EM; Hill JM; Chrousos GP; Kamilaris T; Listwak SJ; Gold PW; Wilder RL
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2374-8. PubMed ID: 2538840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.